Aspiriant LLC recently decreased its holdings in the Schwab U.S. Large-Cap Value ETF (NYSEARCA:SCHV) by 2.8% in the first quarter, according to its Form 13F filing with the SEC. The institutional investor sold 478 shares, leaving them with 16,387 shares valued at $1,245,000. This move by Aspiriant LLC reflects a potential shift in their investment strategy.
Other institutional investors and hedge funds have also been active with SCHV. O Shaughnessy Asset Management LLC increased its stake by 4.7% in the 3rd quarter, Tower Research Capital LLC TRC saw a 242.5% boost in their holdings, and Per Stirling Capital Management LLC increased their stake by 3.2%. These actions indicate a growing interest in the Schwab U.S. Large-Cap Value ETF among investors.
The stock for SCHV saw a slight increase of 0.0% on Friday, opening at $74.07. With a market cap of $10.70 billion and a price-to-earnings ratio of 17.88, the ETF remains stable in a volatile market. The 50-day and 200-day moving averages for SCHV are $74.26 and $72.65, respectively, showing consistent performance over time.
The goal of the Schwab U.S. Large-Cap Value ETF is to track the total return of the Dow Jones U.S. Large-Cap Value Total Stock Market Index. This index represents the large-cap value segment of the Dow Jones U.S. Total Stock Market Index, providing investors with exposure to a diversified range of assets.
Overall, the recent activity surrounding the Schwab U.S. Large-Cap Value ETF suggests a growing interest from institutional investors and a stable performance in the market. DailyBubble sees this as a positive sign for the ETF’s future prospects and believes it could be a valuable addition to investors’ portfolios.